(Q71226331)
Statements
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group (English)
Spruance SL
Tyring SK
DeGregorio B
Miller C